Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic Frontiers

Antisense oligonucleotides (ASOs) are emerging therapeutic agents that modulate gene expression at the RNA level, offering distinct therapeutic advantages over conventional small-molecule drugs and biologics. By directly targeting RNA, ASOs expand the spectrum of druggable targets to include those p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Liping Xu, Huaqun Zhang, Bingchen Jiang, Yuanying Jiang, Hui Lu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-04-01
coleção:	Pharmaceutics
Assuntos:	antisense oligonucleotides RNA-targeted therapeutics chemical modification precision medicine
Acesso em linha:	https://www.mdpi.com/1999-4923/18/4/446
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!